Xevudy 500mg (Sotrovimab Vials) 500mg X 8ml

Xevudy 500mg (Sotrovimab) is an antiviral medication used for early treatment of COVID-19 in high-risk patients. Administered via intravenous infusion, it helps reduce hospitalization risk when given promptly after symptom onset. This 500mg strength comes in a single vial for single-use.

Strength

500mg X 8ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Glaxosmithkline

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xevudy 500mg is used to treat mild-to-moderate COVID-19 in adults and adolescents who are at high risk of progressing to severe disease. It is designed for patients who test positive for SARS-CoV-2 and have symptoms but do not require oxygen therapy. The medication works by binding to the virus to prevent it from entering healthy cells. It is typically given as soon as possible after diagnosis to maximize effectiveness.

Side Effects

Xevudy 500mg is administered by healthcare professionals in a clinical setting. Patients may experience infusion-related reactions, including fever, chills, or nausea during or after administration. Some individuals report mild fatigue or headache following treatment. The effects of the medication are not immediate and work over time to reduce viral load.

Precautions & Warnings

Xevudy 500mg should be stored between 2-8°C and protected from light. It is for single-use only and must be used within the specified timeframe after preparation. Patients with a history of severe allergic reactions to monoclonal antibodies should discuss risks with their healthcare provider. Administration should be supervised by trained medical staff.

Avoid Interactions

Limited data exists on drug interactions with Xevudy 500mg. As a monoclonal antibody, it is not metabolized by liver enzymes, reducing the likelihood of interactions with other medications. However, patients should inform their healthcare provider about all current medications, including over-the-counter drugs and supplements. No specific contraindications have been identified.

Frequently Asked Questions

Xevudy 500mg is used to treat mild-to-moderate COVID-19 in high-risk patients to reduce the risk of severe illness.

It is given as a single intravenous infusion by a healthcare professional in a clinical setting.

No, Xevudy 500mg is not authorized for pre-exposure or post-exposure prevention of COVID-19.

Common effects include infusion-related reactions like fever, chills, or nausea during administration.

No, Xevudy 500mg is an antiviral monoclonal antibody treatment, not a vaccine.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.